Inhibition of lipopolysaccharide-induced microglia activation by calcitonin gene related peptide and adrenomedullin

Molecular and Cellular Neuroscience

Volumn 48, Issue 2, 2011, Pages 151-160

  Consonni, Alessandra ^a   Morara, Stefano ^b   Codazzi, Franca ^a   Grohovaz, Fabio ^a,c,d   Zacchetti, Daniele ^a,d  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b CNR   (Italy)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

Author keywords

CAMP; Chemokines; Neuroinflammation; PGE2; Tumor necrosis factor

Indexed keywords

ADRENOMEDULLIN; CALCITONIN GENE RELATED PEPTIDE; CHEMOKINE; CYCLIC AMP; CYTOKINE; LIPOPOLYSACCHARIDE;

ARTICLE; ASTROCYTE; IN VITRO STUDY; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADRENOMEDULLIN; ANIMALS; ASTROCYTES; CALCITONIN GENE-RELATED PEPTIDE; CELLS, CULTURED; CHEMOKINES; COCULTURE TECHNIQUES; CYCLIC AMP; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MICROGLIA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PEPTIDE FRAGMENTS; RATS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80052373012     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2011.07.006     Document Type: Article

References (58)

1. Amara S.G., Jonas V., Rosenfeld M.G., Ong E.S., Evans R.M. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 1982, 298:240-244.
2. Anthony D.C., Miller K.M., Fearn S., Townsend M.J., Opdenakker G., Wells G.M., Clements J.M., Chandler S., Gearing A.J., Perry V.H. Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS. J. Neuroimmunol. 1998, 87:62-72.
3. Born W., Fischer J.A., Muff R. Receptors for calcitonin gene-related peptide, adrenomedullin, and amylin: the contributions of novel receptor-activity-modifying proteins. Receptors Channels 2002, 8:201-209.
4. Brain S.D., Grant A.D. Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol. Rev. 2004, 84:903-934.
5. Chang C.L., Roh J., Hsu S.Y. Intermedin, a novel calcitonin family peptide that exists in teleosts as well as in mammals: a comparison with other calcitonin/intermedin family peptides in vertebrates. Peptides 2004, 25:1633-1642.
6. Christopoulos G., Perry K.J., Morfis M., Tilakaratne N., Gao Y., Fraser N.J., Main M.J., Foord S.M., Sexton P.M. Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. Mol. Pharmacol. 1999, 56:235-242.
7. Collins T.J. ImageJ for microscopy. Biotechniques 2007, 43:25-30.
8. Colton C.A. Heterogeneity of microglial activation in the innate immune response in the brain. J. Neuroimmune Pharmacol. 2009, 4:399-418.
9. Dackor R., Caron K. Mice heterozygous for adrenomedullin exhibit a more extreme inflammatory response to endotoxin-induced septic shock. Peptides 2007, 28:2164-2170.
10. Doods H., Hallermayer G., Wu D., Entzeroth M., Rudolf K., Engel W., Eberlein W. Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. Br. J. Pharmacol. 2000, 129:420-423.
11. Durham P.L., Vause C.V. Calcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraine. CNS Drugs 2010, 24:539-548.
12. Encinas J.M., Manganas L., Enikolopov G. Nitric oxide and multiple sclerosis. Curr. Neurol. Neurosci. Rep. 2005, 5:232-238.
13. Engelhardt B., Ransohoff R.M. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol. 2005, 26:485-495.
14. Evans B.N., Rosenblatt M.I., Mnayer L.O., Oliver K.R., Dickerson I.M. CGRP-RCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedullin receptors. J. Biol. Chem. 2000, 275:31438-31443.
15. Farez M.F., Quintana F.J., Gandhi R., Izquierdo G., Lucas M., Weiner H.L. Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE. Nat. Immunol. 2009, 10:958-964.
16. Farina C., Aloisi F., Meinl E. Astrocytes are active players in cerebral innate immunity. Trends Immunol. 2007, 28:138-145.
17. Feng Y., Tang Y., Guo J., Wang X. Inhibition of LPS-induced TNF-alpha production by calcitonin gene-related peptide (CGRP) in cultured mouse peritoneal macrophages. Life Sci. 1997, 61:PL 281-287.
18. Flügel A., Odoardi F., Nosov M., Kawakami N. Autoaggressive effector T cells in the course of experimental autoimmune encephalomyelitis visualized in the light of two-photon microscopy. J. Neuroimmunol. 2007, 191:86-97.
19. Geppetti P., Capone J.G., Trevisani M., Nicoletti P., Zagli G., Tola M.R. CGRP and migraine: neurogenic inflammation revisited. J. Headache Pain 2005, 6:61-70.
20. Gomes R.N., Castro-Faria-Neto H.C., Bozza P.T., Soares M.B., Shoemaker C.B., David J.R., Bozza M.T. Calcitonin gene-related peptide inhibits local acute inflammation and protects mice against lethal endotoxemia. Shock 2005, 24:590-594.
21. Gutcher I., Becher B. APC-derived cytokines and T cell polarization in autoimmune inflammation. J. Clin. Invest. 2007, 117:1119-1127.
22. Harris S.G., Padilla J., Koumas L., Ray D., Phipps R.P. Prostaglandins as modulators of immunity. Trends Immunol. 2002, 23:144-150.
23. Hartung H.P., Reiners K., Archelos J.J., Michels M., Seeldrayers P., Heidenreich F., Pflughaupt K.W., Toyka K.V. Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: correlation with magnetic resonance imaging. Ann. Neurol. 1995, 38:186-193.
24. Hay D.L., Conner A.C., Howitt S.G., Takhshid M.A., Simms J., Mahmoud K., Poyner D.R. The pharmacology of CGRP-responsive receptors in cultured and transfected cells. Peptides 2004, 25:2019-2026.
25. Holzer P. Neurogenic vasodilatation and plasma leakage in the skin. Gen. Pharmacol. 1998, 30:5-11.
26. Katayama T., Furuya M., Yamaichi K., Konishi K., Sugiura N., Murafuji H., Magota K., Saito M., Tanaka S., Oikawa S. Discovery of a non-peptide small molecule that selectively mimics the biological actions of calcitonin. Biochim. Biophys. Acta 2001, 1526:183-190.
27. Kerschensteiner M., Meinl E., Hohlfeld R. Neuro-immune crosstalk in CNS diseases. Neuroscience 2009, 158:1122-1132.
28. Kroeger I., Erhardt A., Abt D., Fischer M., Biburger M., Rau T., Neuhuber W.L., Tiegs G. The neuropeptide calcitonin gene-related peptide (CGRP) prevents inflammatory liver injury in mice. J. Hepatol. 2009, 51:342-353.
29. Lassmann H., Brück W., Lucchinetti C. Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol. Med. 2001, 7:115-121.
30. Lehnardt S. Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury. Glia 2010, 58:253-263.
31. Leppert D., Lindberg R.L.P., Kappos L., Leib S.L. Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis. Brain Res. Rev. 2001, 36:249-257.
32. Lindberg R.L., De Groot C.J., Certa U., Ravid R., Hoffmann F., Kappos L., Leppert D. Multiple sclerosis as a generalized CNS disease-comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MS. J. Neuroimmunol. 2004, 152:154-167.
33. Liu J., Chen M., Wang X. Calcitonin gene-related peptide inhibits lipopolysaccharide-induced interleukin-12 release from mouse peritoneal macrophages, mediated by the cAMP pathway. Immunology 2000, 101:61-67.
34. Luebke A.E., Dahl G.P., Roos B.A., Dickerson I.M. Identification of a protein that confers calcitonin gene-related peptide responsiveness to oocytes by using a cystic fibrosis transmembrane conductance regulator assay. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:3455-3460.
35. Ma W., Dumont Y., Vercauteren F., Quirion R. Lipopolysaccharide induces calcitonin gene-related peptide in the RAW264.7 macrophage cell line. Immunology 2010, 130:399-409.
36. Marta M. Toll-like receptors in multiple sclerosis mouse experimental models. Ann. N. Y. Acad. Sci. 2009, 1173:458-462.
37. Martino G., Hartung H.P. Immunopathogenesis of multiple sclerosis: the role of T cells. Curr. Opin. Neurol. 1999, 12:309-321.
38. Martino G., Furlan R., Brambilla E., Bergami A., Ruffini F., Gironi M., Poliani P.L., Grimaldi L.M.E., Comi G. Cytokines and immunity in multiple sclerosis: the dual signal hypothesis. J. Neuroimmunol. 2000, 109:3-9.
39. McCarthy K.D., de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell Biol. 1980, 85:890-902.
40. McLatchie L.M., Fraser N.J., Main M.J., Wise A., Brown J., Thompson N., Solari R., Lee M.G., Foord S.M. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 1998, 393:333-339.
41. Miksa M., Wu R., Cui X., Dong W., Das P., Simms H.H., Ravikumar T.S., Wang P. Vasoactive hormone adrenomedullin and its binding protein: anti-inflammatory effects by up-regulating peroxisome proliferator-activated receptor-gamma. J. Immunol. 2007, 179:6263-6272.
42. Moreno M.J., Terrón J.A., Stanimirovic D.B., Doods H., Hamel E. Characterization of calcitonin gene-related peptide (CGRP) receptors and their receptor-activity-modifying proteins (RAMPs) in human brain microvascular and astroglial cells in culture. Neuropharmacology 2002, 42:270-280.
43. Muzio L., Martino G., Furlan R. Multifaceted aspects of inflammation in multiple sclerosis: the role of microglia. J. Neuroimmunol. 2007, 191:39-44.
44. Poyner D.M., Sexton P.M., Marshall I., Smith D.M., Quirion R., Born W., Muff R., Fischer J.A., Foord S.M. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol. Rev. 2002, 54:233-246.
45. Recober A., Russo A.F. Calcitonin gene-related peptide: an update on the biology. Curr. Opin. Neurol. 2009, 22:241-246.
46. Redford C.J., Kapoor P., Smith K.J. Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. Brain 1997, 120:2149-2157.
47. Saura J. Microglial cells in astroglial cultures: a cautionary note. J. Neuroinflammation 2007, 4:26.
48. Schreiner B., Heppner F.L., Becher B. Modeling multiple sclerosis in laboratory animals. Semin. Immunopathol. 2009, 31:479-495.
49. Smith S.R., Terminelli C., Denhardt G. Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 in endotoxemic mice. J. Pharmacol. Exp. Ther. 2000, 293:136-150.
50. Szczucinski A., Losy J. Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies. Acta Neurol. Scand. 2007, 115:137-146.
51. Tanaka K.F., Kashima H., Suzuki H., Ono K., Sawada M. Existence of functional beta1- and beta2-adrenergic receptors on microglia. J. Neurosci. Res. 2002, 70:232-237.
52. Temmesfeld-Wollbrück B., Hocke A.C., Suttorp N., Hippenstiel S. Adrenomedullin and endothelial barrier function. Thromb. Haemost. 2007, 98:944-951.
53. Tsujikawa K., Yayama K., Hayashi T., Matsushita H., Yamaguchi T., Shigeno T., Ogitani Y., Hirayama M., Kato T., Fukada S., Takatori S., Kawasaki H., Okamoto H., Ikawa M., Okabe M., Yamamoto H. Hypertension and dysregulated proinflammatory cytokine production in receptor activity-modifying protein 1-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:16702-16707.
54. van Rossum D., Hanisch U.K., Quirion R. Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors. Neurosci. Biobehav. Rev. 1997, 21:649-678.
55. Walker C.S., Conner A.C., Poyner D.R., Hay D.L. Regulation of signal transduction by calcitonin gene-related peptide receptors. Trends Pharmacol. Sci. 2010, 31:476-483.
56. Wang Z., Ma W., Chabot J.G., Quirion R. Cell-type specific activation of p38 and ERK mediates calcitonin gene-related peptide involvement in tolerance to morphine-induced analgesia. FASEB J. 2009, 23:2576-2586.
57. Wong L.Y., Cheung B.M., Li Y.Y., Tang F. Adrenomedullin is both proinflammatory and antiinflammatory: its effects on gene expression and secretion of cytokines and macrophage migration inhibitory factor in NR8383 macrophage cell line. Endocrinology 2005, 146:1321-1327.
58. Wu R., Zhou M., Wang P. Adrenomedullin and adrenomedullin binding protein-1 downregulate TNF-alpha in macrophage cell line and rat Kupffer cells. Regul. Pept. 2003, 112:19-26.